NASDAQ:CELC - Celcuity Inc.
$23.29
 $0.78
+3.47%
2:35PM EDT
2019-02-15
Celcuity, Inc., incorporated on September 15, 2017, is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Companys proprietary CELx diagnostic platform uses a patients living tumor cells to identify the specific abnormal cellular process driving a patients cancer and the targeted therapy that best treats it. CELx platform provides traditional molecular diagnostics, which provides a snapshot of the genetic mutations present in a patients tumor because they analyze dead cells. Using dead cells prevents molecular diagnostics from analyzing in real-time the dynamic cellular activities, known as cell signaling, that regulate cell proliferation or survival. The Companys Cell microenvironment culturing living tumor cells poses three primary challenges. First, there is typically only a small amount of patient tumor tissue available. Second, the tumor cells often die once they are removed from the tumor tissue. Third, tumor cells that do survive are difficult to maintain. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CELC     avg for
industry  
  avg for
sector  
42 stocks weight:  68. 19   0. 00   0. 00  
42 stocks rank:  2. 33 K 1. 86 K 1. 09 K
# analyst opinions:  2. 00   14. 92   14. 43  
mean recommendation:  2. 00   1. 91   1. 93  

quick ratio:  23. 71   5. 37   1. 81  
current ratio:  24. 11   5. 69   2. 19  

target price low:  35. 00   88. 97   117. 82  
target price avg:  35. 50   115. 19   141. 96  
target price high:  36. 00   143. 40   163. 16  
1-yr high:  30. 77   124. 30   142. 77  
last close:  22. 51   101. 85   127. 84  
50-day avg:  22. 83   98. 27   122. 46  
200-day avg:  24. 00   99. 72   122. 70  
1-yr low:  13. 55   78. 19   100. 16  
volume:  1. 09 K 2. 38 M 4. 64 M
50-day avg volume:  8. 33 K 3. 31 M 4. 94 M
200-day avg volume:  16. 89 K 3. 23 M 4. 28 M

1-day return:  0. 54 % 0. 22 % 0. 48 %
this week return:  3. 49 % 1. 77 % 2. 01 %
12-wk return:  -10. 43 % 6. 56 % 3. 33 %
52-wk return:  29. 46 % -2. 23 % 14. 35 %

enterprise value (EV):  198. 20 M 55. 17 B 104. 51 B
market cap:  228. 70 M 49. 01 B 96. 46 B
EBITDA:  -7. 62 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -26. 00   -91. 79   2. 29  
total debt:  27. 04 K 13. 73 B 16. 57 B
debt/equity:  0. 10   258. 01   110. 73  
net income (common):  -7. 38 M 2. 37 B 3. 58 B

shares outstanding:  10. 16 M 607. 99 M 1. 22 B
shares:  5. 35 M 605. 53 M 1. 15 B
shares short:  109. 09 K 11. 62 M 12. 55 M
shares short prior month:  100. 95 K 11. 95 M 13. 44 M
short ratio:  9. 34   4. 82   3. 10  
short % of float:  1. 89 % 6. 19 % 2. 82 %
total cash/share:  2. 24   12. 02   11. 46  
total cash:  22. 78 M 7. 41 B 7. 37 B
free cash flow:  -3. 43 M 95. 99 M 2. 04 B
operating cash flow:  -5. 67 M 164. 74 M 3. 04 B

book value:  2. 65   14. 43   28. 26  
price/book:  8. 49   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  14. 03 % --- ---
1-yr mean volatility:  0. 15 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 73   3. 03   4. 09  
forward EPS:  -0. 82   4. 33   6. 99  
P/E:  -30. 84   6. 11   26. 91  
forward P/E:  -26. 60   8. 38   10. 48  
PE/G:  18. 35   0. 37   5. 61  
growth:  -1. 68 % 683. 72 % 104. 79 %
earnings high:  -0. 17   1. 27   1. 66  
earnings avg:  -0. 19   1. 01   1. 53  
earnings low:  -0. 20   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -15. 98 % -3. 27 % 3. 81 %
return on equity:  -24. 71 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  0. 38   1. 21   0. 93  
sharpe (1yr):  0. 73   0. 06   0. 98  

held % insiders:  49. 70 % 6. 46 % 3. 21 %
held % institutions:  15. 43 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : CELC
.    + 4.014 =         4.014 :: INITIAL WEIGHT
.  + 362.576 =        366.59 :: inverse volume-to-price addition
.  + 434.183 =       800.774 :: spline projection addition
.  - 119.756 =       681.018 :: poor performance penalty
.    x 1.334 =       908.159 :: one-year gains+dividend factor
.    x 4.125 =      3746.104 :: 13 weeks' performance factor
.    x 1.492 =      5591.018 :: industry recommendation factor
.    x 2.098 =     11730.864 :: symbol recommendation factor
.    x 0.998 =     11712.114 :: return on assets factor
.    x 0.998 =     11683.169 :: return on equity factor
.    x 4.181 =     48849.373 :: current ratio factor
.    x 1.022 =     49913.059 :: quick ratio factor
.    x 1.052 =     52517.134 :: short ratio factor
.    x 2.176 =    114264.092 :: price-to-book factor
.      x 1.0 =    114286.233 :: debt-to-equity factor
.    x 1.934 =    221079.623 :: P/E weight
.    x 0.483 =    106815.843 :: PE/G factor
.    x 1.644 =    175576.743 :: beta factor
.    x 0.731 =    128376.278 :: sharpe factor
.    x 1.804 =    231615.376 :: target low factor
.    x 1.253 =    290264.693 :: target mean factor
.    x 1.077 =    312735.178 :: target high factor
.    x 1.066 =    333254.611 :: industry 12-weeks return
.    x 0.999 =     332767.22 :: "drift" penalty 3 days ago
.    x 0.999 =    332596.429 :: overall "drift" factor
.     x 0.86 =    285943.354 :: largest single-day jump factor
.     x 1.01 =    288798.546 :: mean volatility factor
.    x 1.098 =    316991.178 :: 42-day mean volatility factor
.      x 1.0 =    317012.455 :: factor hist industry gain for week 06
.   cubeRoot =        68.186 :: reduced for readability
.                     68.186 :: FINAL WEIGHT for NASDAQ:CELC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org